About
Antibodies, Fusion Proteins, Small Molecules, Vaccine
Areas of Focus
Categories
Biologics & BiopharmaceuticalVaccineSmall Molecule PharmaceuticalAntibody
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
337
By Phase
PHASE2: 2PHASE1/PHASE2: 2PHASE1: 1
By Status
RECRUITING: 3COMPLETED: 1TERMINATED: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06846554Lead Sponsor
"A Trial of APL-9796'' in Adults With Pulmonary Hypertension"
PHASE2Recruiting
48 participants
Started: Apr 9, 2025 · Completed: Sep 30, 2027
NCT06399757Lead Sponsor
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
PHASE1/PHASE2Recruiting
100 participants
Started: Jun 18, 2024 · Completed: May 31, 2027
NCT06372717Lead Sponsor
A Study to Investigate APL-4098 Alone and/or in Combination With Azacitidine in R/R AML and High-Risk MDS
PHASE1/PHASE2Recruiting
122 participants
Started: Jun 4, 2024 · Completed: Apr 1, 2027
NCT06436183Lead Sponsor
A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
PHASE2Completed
62 participants
Started: May 1, 2024 · Completed: Aug 12, 2025
NCT04752371Lead Sponsor
A Study to Evaluate Camoteskimab in Participants With Still's Disease
PHASE1Terminated
5 participants
Started: Mar 25, 2021 · Completed: May 24, 2022
Locations (1)
Headquarters
Cambridge, UK
Map
Loading map...